Voyager Therapeutics (VYGR) Net Income towards Common Stockholders Growth (5y) (2019 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Net Income towards Common Stockholders Growth (5y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Voyager Therapeutics | 195.27 Mn | 78.93 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.06% |
| Mar 31, 2026 | -1.78% |
| Dec 31, 2025 | 32.61% |
| Sep 30, 2025 | -18.39% |
| Jun 30, 2025 | -29.24% |
| Mar 31, 2025 | -5.35% |
| Dec 31, 2024 | -22.36% |
| Sep 30, 2024 | 9.63% |
| Jun 30, 2024 | -23.81% |
| Mar 31, 2024 | 16.05% |
| Dec 31, 2023 | 35.11% |
| Sep 30, 2023 | -5.01% |
| Jun 30, 2023 | 2.76% |
| Mar 31, 2023 | 52.42% |
| Dec 31, 2022 | -14.90% |
| Sep 30, 2022 | 22.47% |
| Jun 30, 2022 | -0.22% |
| Mar 31, 2022 | -5.07% |
| Dec 31, 2021 | 19.03% |
| Sep 30, 2021 | -22.82% |